FASEB BioAdvances

335 papers and 2.8k indexed citations i.

About

The 335 papers published in FASEB BioAdvances in the last decades have received a total of 2.8k indexed citations. Papers published in FASEB BioAdvances usually cover Molecular Biology (153 papers), Public Health, Environmental and Occupational Health (47 papers) and Physiology (40 papers) specifically the topics of Extracellular vesicles in disease (16 papers), Health and Medical Research Impacts (16 papers) and Innovations in Medical Education (15 papers). The most active scholars publishing in FASEB BioAdvances are George E. Thibault, Abdullah Al Mamun, Md. Abdul Alim Al‐Bari, James Clancy, Crislyn D’Souza‐Schorey, Andrew M. Leidal, Jayanta Debnath, Hubert Hondermarck, Michael Hortsch and Olle ten Cate.

In The Last Decade

Fields of papers published in FASEB BioAdvances

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in FASEB BioAdvances. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in FASEB BioAdvances

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in FASEB BioAdvances. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in FASEB BioAdvances with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025